PTG-007

N/A

Report date: 2025/07/29 20:00:11

Base Information

Drug NamePTG-007
Drug Alias NamePTG-007
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Tregs
Mechanisms of ActionT lymphocyte replacements
TargetsNot applicable
Therapy Area/IndicationsDiabetes Mellitus, Type 1Multiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPoland
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPoltreg SA
China Registration ClassN/A

Develop Information

Active CompaniesPoltreg SA
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1Multiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A